DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by Goldman Sachs Group Inc.

Goldman Sachs Group Inc. decreased its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 28.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 522,137 shares of the medical instruments supplier’s stock after selling 211,840 shares during the quarter. Goldman Sachs Group Inc. owned about 0.25% of DENTSPLY SIRONA worth $18,583,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in XRAY. Parkside Financial Bank & Trust grew its holdings in DENTSPLY SIRONA by 33.3% in the 4th quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock valued at $42,000 after buying an additional 292 shares during the period. Beach Investment Counsel Inc. PA increased its position in DENTSPLY SIRONA by 1.4% during the fourth quarter. Beach Investment Counsel Inc. PA now owns 22,125 shares of the medical instruments supplier’s stock worth $787,000 after purchasing an additional 306 shares during the last quarter. VisionPoint Advisory Group LLC raised its stake in DENTSPLY SIRONA by 104.2% during the third quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock worth $26,000 after purchasing an additional 395 shares during the period. Treasurer of the State of North Carolina boosted its holdings in shares of DENTSPLY SIRONA by 0.5% in the 3rd quarter. Treasurer of the State of North Carolina now owns 92,842 shares of the medical instruments supplier’s stock valued at $3,171,000 after purchasing an additional 470 shares during the last quarter. Finally, UMB Bank n.a. grew its stake in shares of DENTSPLY SIRONA by 0.6% during the 4th quarter. UMB Bank n.a. now owns 74,181 shares of the medical instruments supplier’s stock valued at $2,640,000 after buying an additional 473 shares during the period. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on XRAY shares. Needham & Company LLC reduced their target price on DENTSPLY SIRONA from $42.00 to $36.00 and set a “buy” rating on the stock in a report on Friday, May 3rd. Piper Sandler reiterated a “neutral” rating and set a $32.00 target price (down previously from $35.00) on shares of DENTSPLY SIRONA in a report on Friday, May 3rd. Evercore ISI dropped their target price on shares of DENTSPLY SIRONA from $35.00 to $28.00 and set an “outperform” rating for the company in a research report on Tuesday. Barrington Research reduced their price target on shares of DENTSPLY SIRONA from $41.00 to $38.00 and set an “outperform” rating on the stock in a research report on Friday, May 3rd. Finally, Robert W. Baird dropped their price objective on shares of DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating for the company in a research report on Friday, May 3rd. Five investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $34.44.

DENTSPLY SIRONA Stock Performance

NASDAQ:XRAY opened at $25.16 on Thursday. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.43 and a quick ratio of 0.97. The firm has a 50-day moving average of $27.94 and a two-hundred day moving average of $31.81. The stock has a market cap of $5.22 billion, a P/E ratio of -57.18, a PEG ratio of 1.12 and a beta of 1.04. DENTSPLY SIRONA Inc. has a 1-year low of $24.82 and a 1-year high of $41.65.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, meeting analysts’ consensus estimates of $0.42. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The firm had revenue of $953.00 million during the quarter, compared to the consensus estimate of $969.45 million. During the same quarter in the prior year, the business posted $0.39 earnings per share. DENTSPLY SIRONA’s revenue for the quarter was down 2.6% on a year-over-year basis. On average, research analysts expect that DENTSPLY SIRONA Inc. will post 2.02 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 12th. Stockholders of record on Friday, June 28th will be given a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 2.54%. The ex-dividend date is Friday, June 28th. DENTSPLY SIRONA’s payout ratio is currently -145.45%.

Insider Activity

In other news, Director Gregory T. Lucier purchased 3,577 shares of the firm’s stock in a transaction that occurred on Friday, May 31st. The stock was acquired at an average cost of $27.95 per share, for a total transaction of $99,977.15. Following the completion of the purchase, the director now owns 58,374 shares of the company’s stock, valued at $1,631,553.30. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 0.52% of the company’s stock.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.